![Amy M. McCord](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Amy M. McCord
General Counsel bei
HEDGEPATH PHARMACEUTICALS INC
Profil
Amy M.
McCord is currently Director-Regulatory Affairs at Inhibitor Therapeutics, Inc. since 2019.
Former positions include Director-Chemistry & Manufacturing at BioVest International, Inc., Director-Regulatory Affairs at Davis Strategic Innovations, Inc. from 2016 to 2019, Senior Manager-Clinical Research at Accentia Biopharmaceuticals, Inc. from 2009 to 2015, and Scientist at OSO BioPharmaceuticals Manufacturing LLC from 2015 to 2016.
Education includes a doctorate from USF Health Morsani College of Medicine conferred in 2005.
Aktive Positionen von Amy M. McCord
| Unternehmen | Position | Beginn |
|---|---|---|
| HEDGEPATH PHARMACEUTICALS INC | General Counsel | 01.01.2019 |
Ehemalige bekannte Positionen von Amy M. McCord
| Unternehmen | Position | Ende |
|---|---|---|
Davis Strategic Innovations, Inc.
 Davis Strategic Innovations, Inc. Engineering & ConstructionIndustrial Services Provides engineering, weapons of mass destruction and bioterrorism issues specialty services | General Counsel | 01.01.2019 |
OSO BioPharmaceuticals Manufacturing LLC
 OSO BioPharmaceuticals Manufacturing LLC Pharmaceuticals: MajorHealth Technology Delivers the sterile contract manufacturing and drug development services | Corporate Officer/Principal | 01.11.2016 |
| ACCENTIA BIOPHARMACEUTICALS INC | Corporate Officer/Principal | 01.04.2015 |
BioVest International, Inc.
 BioVest International, Inc. Medical SpecialtiesHealth Technology Develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers | Corporate Officer/Principal | - |
Ausbildung von Amy M. McCord
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
14
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology Develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers | Health Technology |
Accentia Biopharmaceuticals, Inc.
 Accentia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets biopharmaceuticals | Health Technology |
OSO BioPharmaceuticals Manufacturing LLC
OSO BioPharmaceuticals Manufacturing LLC Pharmaceuticals: MajorHealth Technology Delivers the sterile contract manufacturing and drug development services | Health Technology |
Davis Strategic Innovations, Inc.
Davis Strategic Innovations, Inc. Engineering & ConstructionIndustrial Services Provides engineering, weapons of mass destruction and bioterrorism issues specialty services | Industrial Services |
Inhibitor Therapeutics, Inc.
 Inhibitor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
USF Health Morsani College of Medicine
 USF Health Morsani College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
